- Hadassah BrainLabs builds on the expertise of Hadassah scientists and provides guidance to researchers from academia and industry along with dedicated laboratories and core facilities.
- Founded in 2013 as a National Knowledge Center for Research on Brain Disorders with the support of the Israel Ministry of Science and Technology, and supported in part by the Ministry until 2020, Hadassah BrainLabs is a unique resource serving Israeli academia and industry.
- We offer the widest range of disease models complemented by state-of-the-art capabilities in histopathology, genomics and access to the advanced brain imaging facilities of the Wohl Institute for Translational Medicine of Hadassah Ein Karem.
- Disease models (genetic or interventional) are available for Alzheimer’s disease, Parkinson’s disease, vascular dementia, multiple sclerosis, ALS, prion diseases, epilepsy, depression, schizophrenia, attention deficit hyperactivity disorder (ADHD), autism and other neuropsychiatric disorders. We evaluate a wide range of outcome measures relevant to these disorders.
- Advanced computerized technologies located in SPF-certified facilities are used for behavioral analysis of motor, cognitive, emotional and social domains in rodent models.
- Unique expertise of renowned clinician-scientists bridges the basic-clinical divide to help researchers who are interested in developing new diagnostic approaches and novel therapies.
- Advanced capabilities are available to take studies from experimental design to patent application and academic publication.
- We provide practical assistance with regulatory processes including ethical approval, design of experiments to meet regulatory requirements and comprehensive reports to regulatory bodies.